Literature DB >> 4195789

Ineffectiveness of L-dopa as supplement to penicillamine in a case of Wilson's disease.

J P Morgan, T J Preziosi, J R Bianchine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4195789     DOI： 10.1016/s0140-6736(70)91422-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

2.  Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease.

Authors:  Henryk Barthel; Wieland Hermann; Regine Kluge; Swen Hesse; David R Collingridge; Armin Wagner; Osama Sabri
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

3.  The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography.

Authors:  B J Snow; M Bhatt; W R Martin; D Li; D B Calne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

4.  Dopamine transporter imaging with [123I]-beta-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease.

Authors:  B Jeon; J M Kim; J M Jeong; K M Kim; Y S Chang; D S Lee; M C Lee
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.